Zingiber officinale (ginger, II), Citrullus colocynthis (CC, III) and Anethum graveolens (dill, IV) are functional medicinal plants containing beneficial compounds and some evidence exists on their anti-diabetic, anti-inflammatory and hypolipidemic activities. The objective of this study was to evaluate the antihyperglycemic and antihyperlipidemic potential of various extracts of these plants with different polarities in experiments on streptozotocin-induced diabetic rats. Test animals (n = 112) were randomly divided into control, diabetic, diabetic+chloroform extract, diabetic+carbon tetrachloride extract, diabetic+hydroalcoholic extract, and diabetic+aqueous extract groups. Rats were made diabetic by a single injection of streptozotocin (STZ, 60 mg/kg). The plant extracts were daily administered (100 mg/kg, i.p.) for 3 weeks. Serum glucose and lipid levels were measured at different weeks. All extracts of ginger and dill as well as carbon tetrachloride and hydroalcoholic extracts of CC significantly reduced serum glucose level in diabetic groups. In addition, some plants extracts approppriately and significantly improved serum lipid levels including triglyceride, total cholesterol, HDLcholesterol, and LDL cholesterol in diabetic rats. According to extract polarities and components, all ginger extracts exerted hypoglycemic effect, however, hydroalcoholic extract showed the best potential to appropriately modify serum lipids in diabetic condition. In addition, hydroalcoholic extracts of C. colocynthis and A. graveolens had the best anti-diabetic potential which could be related to better extraction of bioactive components by polar or non-polar organic and aqueous solvents from these medicinal herbs.
Similar content being viewed by others
References
A. I. Vinik and E. Vinik, Am. J. Manag. Care, 9, S63 – S80 (2003).
C. A. Reasner, J. Cardiovasc. Pharmacol., 52, 136 – 144 (2008).
D. E. Moller, Nature, 414, 821 – 827 (2001).
G. Suji and S.Sivakami, Cell. Mol. Biol., 49, 635 – 639 (2003).
K. Shapiro and W. C. Gong, J. Am. Pharm. Assoc., 42, 217 – 226 (2002).
M. S. Akash, K. Rehman, M. Tariq, et al., Crit. Rev. Eukaryot. Gene Expr., 25, 91 – 112 (2015).
F. Shidfar, A. Rajab, T. Rahideh, et al., J. Complement. Integr. Med., 12, 165 – 170 (2015).
G. Saravanan, P. Ponmurugan, M. A. Deepa, et al., J. Sci. Food Agric., 94, 2972 – 2977 (2014).
T. Arablou, N. Aryaeian, M. Valizadeh, et al., Int. J. Food Sci. Nutr., 65, 515 – 520 ((2005).
M. M. Elseweidy, N. N. Younis, S. E. Elswefy, et al., Nat. Prod. Res., 29, 961 – 965 (2015).
U. Bhandari, R. Kanojia, K. K. Pillai, et al., J. Ethnopharmacol., 97, 227 – 230
H. Shafaei, J. S. Rad, A. Delazar, et al., Adv. Biomed. Res., 3, 258 (2014).
B. Barghamdi, F. Ghorat, K. Asadollahi, et al., J. Pharm. Bioallied. Sci., 8, 130 – 134 (2016).
M. T. Goodarzi, I. Khodadadi, H. Tavilani, et al., J. Trop. Med., 2016, 1098916 (2016).
E. A. Oshaghi, I. Khodadadi, F. Mirzaei, et al., J. Pharm. (Cairo), 2017, 6081374 (2017).
A. H. Hiba, R. R. Ayad Mohammed, et al., Pharm. Anal. Acta, 3, 9 (2012).
I. H. Abdullah, A. R. Hassaan, Z. A. S. Munavvar, et al., J. Ethnopharmacol., 155, 54 – 66 (2014).
N. Mishra, Vet. World, 6, 502 – 507 (2013).
S. S. Rita de Cássia, N. A. Luciana, and S. Damião Pergentino, Molecules, 18, 1227 – 1254 (2013).
A. J. Scheen, N. Esser, and N. Paquot, Diabetes Metab., 41, 183 – 194 (2015).
B. M. Kochikuzhyi, K. Devi, and S. R. Fattepur, Indian J. Pharmacol., 42, 142 – 145 (2010).
M. Kusunki and K. Thsutsumi, J. Med. Invest., 54, 243 – 247 (2007).
C. C. de Menezes Patrício Santos, M. S. Salvadori, V. G. Mota, et al., Neurosci. J., 2013, Article ID 949452, (2013).
N. Zulbadli, H. Alwi, and K. Halim, Int. J. Eng.. Tech., 11, 79 – 84 (2011).
M. C. Sabu and R. Kuttan, J. Ethnopharmacol., 81, 155 – 160 (2002).
R. Gupta, A. K. Sharma, and M. P. Dobhal, J. Diabetes, 3, 29 – 37 (2011).
K. B. Zhong-Ji Qian, K. Kyong-Hwa, and K. Se-Kwon, Biotech. Bioproc. Eng., 17, 1031 – 1040 (2012).
J. Y. Salib, H. N. Michael, and E. F. Eskande, Pharmacognosy Res., 5, 22 – 29 (2013).
A. T. Shulgin, T. Sargent, and C. Naranjo, Psychopharmacol. Bul., 4, PMID 5615546 (1967).
M. S. Akash, K. Rehman, M. Tariq, et al., Crit. Rev. Eukaryot. Gene Expr., 25, 91 – 112 (2015).
F. Shidfar, A. Rajab, T. Rahideh, et al., J. Complement. Integr. Med., 12, 165 – 170 (2015).
G. Saravanan, P. Ponmurugan, M. A. Deepa, et al., J. Sci. Food Agric., 94, 2972 – 2977 (2014).
A. J. Krentz, Diabetes Obes. Metab., 5, S19 – 27 (2003).
B. G. Brown, X. Q. Zhao, D. E. Sacco, et al., Circulation, 87, 1781 – 1791 (1993).
T. Arablou, N. Aryaeian, M. Valizadeh, et al., Int. J. Food Sci. Nutr., 65, 515 – 520 (2014).
B. O. Iranloye, A. P. Arikawe, G. Rotimi, et al., Niger. J. Physiol. Sci., 26, 89 – 96 (2011).
M. P. Rani, M. S. Krishna, K. P. Padmakumari, et al., J. Sci. Food Agric., 92, 1948 – 1955 (2012).
F. Al-Ghaithi, M. R. El-Ridi, E. Adeghate, et al., Mol. Cell. Biochem., 261, 143 – 149 (2004).
N. Takahashi, L. Yao, M. Kim, et al., Mol. Nutr. Food Res., 57, 1295 – 1299 (2013).
Acknowledgments
The authors appreciate Mojtaba Chaichi, EFL/ESL educator, for proofreading the initial draft of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmadi, A., Roghani, M., Parsianfard, M. et al. Antihyperglycemic and Antihyperlipidemic Evaluation of Zingiber officinale, Anethum graveolens and Citrullus colocynthis Extracts with Different Polarities in Streptozotocin-Induced Diabetic Rats. Pharm Chem J 55, 1062–1070 (2022). https://doi.org/10.1007/s11094-021-02538-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-021-02538-2